Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres
about
Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatmentPhotochemical internalization-mediated delivery of chemotherapeutic agents in human breast tumor cell lines.Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study.Uptake of novel medical therapies in the general population.Use and delivery of granulocyte colony-stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy-single-centre experienceReal-world impact of granulocyte-colony stimulating factor on febrile neutropeniaReal-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age.Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis.Incidence of febrile neutropenia in early stage breast cancer patients receiving adjuvant FEC-D treatment.Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis.Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients.Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand.
P2860
Q26824773-63DB0979-5367-4A99-9CA7-FBA8B4C0A821Q34014475-F31197C2-9FB9-4A53-863B-87D5DDD62A99Q34293797-565BB78F-4FBA-4700-A359-A9B80F53BDFAQ35026985-7C387B0D-86FE-47D9-AEBB-1AFF0590C00CQ36136876-8E745BAF-335C-4E6F-A085-24CEF7604530Q36897773-04D22A02-5D6A-4CCF-9DC6-BA9C84858738Q36989067-AF4A89B3-8C54-4DF7-A269-6017EEA3A388Q37976586-2C29258D-E054-4EA9-AB4D-11E98F0A58A7Q38226486-3896F728-47DC-4714-BAD9-B4497767AC8DQ38682028-FDF115DA-6AD9-4C69-BA60-D8EF70969605Q48119796-45A7FEF0-23CB-48EB-B642-ACE52249ED4CQ51732668-1FA07DCA-C415-4D4F-8C08-4C13C3FC1CF9
P2860
Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Real-world experience with adj ...... ntario regional cancer centres
@ast
Real-world experience with adj ...... ntario regional cancer centres
@en
type
label
Real-world experience with adj ...... ntario regional cancer centres
@ast
Real-world experience with adj ...... ntario regional cancer centres
@en
prefLabel
Real-world experience with adj ...... ntario regional cancer centres
@ast
Real-world experience with adj ...... ntario regional cancer centres
@en
P2093
P2860
P356
P1433
P1476
Real-world experience with adj ...... ntario regional cancer centres
@en
P2093
A Robinson
J L Verreault
S Alkhayyat
S F Husain
T Vandenberg
W M Hopman
Y Madarnas
P2860
P304
P356
10.3747/CO.V18I3.751
P577
2011-06-01T00:00:00Z